HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $802,000 | +1.4% | 2,426,300 | -0.3% | 0.74% | -22.9% |
| Q1 2020 | $791,000 | -55.4% | 2,434,000 | -3.7% | 0.96% | -39.9% |
| Q4 2019 | $1,774,000 | +13.4% | 2,527,000 | +7.4% | 1.59% | +18.0% |
| Q3 2019 | $1,564,000 | +58.9% | 2,353,153 | +297.1% | 1.35% | +95.6% |
| Q2 2019 | $984,000 | -36.5% | 592,620 | -4.4% | 0.69% | -32.5% |
| Q1 2019 | $1,550,000 | +35.6% | 619,920 | +37.8% | 1.02% | +15.2% |
| Q4 2018 | $1,143,000 | -9.4% | 449,950 | +80.2% | 0.89% | +17.0% |
| Q3 2018 | $1,261,000 | +54.9% | 249,700 | 0.0% | 0.76% | +29.8% |
| Q2 2018 | $814,000 | -10.1% | 249,700 | -0.2% | 0.58% | -28.5% |
| Q1 2018 | $905,000 | – | 250,100 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |